Med LifeBSE:M 91 Interest Coverage is 1.62 as of Mar. 2026, which is 35% below its 10-year median of 2.51. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.82 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 452 Healthcare Providers & Services companies, Med Life ranks worse than 86.28% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Med Life's
Operating Income
for the
three
months ended in Mar. 2026 was lei44 Mil. Med Life's Interest Expense for the
three
months ended in Mar. 2026 was lei-27 Mil.
Med Life's interest coverage for the quarter that ended in Mar. 2026 was 1.62.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Med Life's Interest Coverage or its related term are showing as below:
BSE:M'
s Interest Coverage Range Over the Past 10 Years
Min: 1.23 Med: 2.51 Max: 8.2
Current: 1.75
BSE:M's Interest Coverage is ranked worse than 86.28% of 452
companies
in the Healthcare Providers & Services industry
Industry Median: 7.99
vs BSE:M: 1.75
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Med Life Interest Coverage Related Terms
Med Life Interest Coverage Historical Data
* Premium members only.
The historical data trend for Med Life's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BSE:M vs HCA, THC, DVA: Interest Coverage Comparison
For the Medical Care Facilities subindustry, Med Life's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Med Life's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (BSE:M) has a Interest Coverage of 1.62 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Med Life and its competitors. This is 35% below median its historical median of 2.51. Over the past decade, Med Life's Interest Coverage has ranged from 1.23 to 8.20. According to the industry distribution chart, Med Life ranks #390 out of 452 companies in the Healthcare Providers & Services industry, placing it in the top 86.3%.
Is Med Life's Interest Coverage too high?
Med Life's current Interest Coverage of 1.62 is 35% below median its 10-year median of 2.51. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 8.20. The Healthcare Providers & Services industry median Interest Coverage is 7.99. Med Life's value of 1.62 is 79.7% below this industry median. Based on the distribution chart, Med Life ranks #390 out of 452 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Med Life has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Interest Coverage compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #390 out of 452 companies for Interest Coverage. This places Med Life in the lower half of its industry. The industry median Interest Coverage is 7.99. Med Life's value of 1.62 is 79.7% below this benchmark. Historically, Med Life's own Interest Coverage has ranged from 1.23 to 8.20 over the past decade. While the company's 10-year median is 2.51 vs. the industry median of 7.99, Med Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.99, based on 452 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Interest Coverage of 1.62 is 79.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Interest Coverage is 1.62, which is 35% below median its own 10-year median of 2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.82, compared to a current price of lei11.40 — trading 45.8% above its estimated fair value. The current Interest Coverage is 1.62, which is 35% below median its 10-year median of 2.51 and 79.7% below the Healthcare Providers & Services industry median of 7.99. Med Life's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Med Life (BSE:M), the current Interest Coverage is 1.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (BSE:M) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.40 is trading 45.8% above its estimated GF Value™ of lei7.82.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
Interest Coverage: 1.62 (35% below median its 10-year median of 2.51)
GF Value™: lei7.82 vs. price of lei11.40 (45.8% above fair value)
Industry Position: 79.7% below the Healthcare Providers & Services median (#390 of 452)
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score
Get the complete analysis for BSE:M
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:M has been successfully added to your 
